Role for heparin-binding growth factors in glucose-induced vascular dysfunction

Diabetes

Volumn 47, Issue 11, 1998, Pages 1771-1778

  Stephan, Clifford C ^a   Chang, Katherine C ^b   Lejeune, Wanda ^a   Erichsen, David ^a   Bjercke, Robert J ^a   Rege, Ajay ^a   Biediger, Ronald J ^a   Kogant, Timothy P ^a   Brock, Tommy A ^a   Williamson, Joseph R ^b   Tilton, Ronald G ^a  

^a TEXAS BIOTECHNOLOGY CORPORATION   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GLUCOSE; MONOCLONAL ANTIBODY; SORBITOL; SURAMIN; VASCULOTROPIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD VESSEL PERMEABILITY; DIABETIC ANGIOPATHY; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD FLOW VELOCITY; BLOOD VESSELS; CAPILLARY PERMEABILITY; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; GLUCOSE; GRANULATION TISSUE; HUMANS; LYMPHOKINES; MALE; MICE; MICE, INBRED BALB C; RATS; RATS, SPRAGUE-DAWLEY; SORBITOL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031720362     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.11.1771     Document Type: Article

References (66)

1. Ferrara N, Houck L, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32, 1992
2. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor: an endothelial cell mitogen related to platelet derived growth factor. Science 246:1309-1312, 1989
3. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18:4-25, 1997
4. Ratajska A, Tony RJ, Kitten GT, Kolker SJ, Tomanek RJ: Modulation of cell migration and vessel formation by vascular endothelial growth factor and basic fibroblast growth factor in cultured embryonic heart. Dev Dyn 203:399-407, 1995
5. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
6. Adamis A, Miller J, Bernai M-T, D'Amico D, Folkman J, Yeo T-K, Yeo K-T: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450, 1994
7. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, Plouet J: Detection of vascuiar endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 112:1476-1482, 1994
8. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E: Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 80:241-245, 1996
9. Miller JW, Adamis AP Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, Yeo T-K, Yeo K-T: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model Am J Pathol 145:574-584, 1994
10. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH: Vascular endothelial growth factor/Vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 92:905-909, 1995
11. Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR: Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 37:855-868, 1996
12. Stone J, Chart-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E: Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci 37:290-299, 1996
13. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LEH: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 92:10457-10461, 1995
14. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D'Amore PA, Miller JW: Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 114:66-71, 1996
15. Robinson GS, Pierce EA, Rook SL. Foley E, Webb R, Smith LEH: Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Prvc Natl Acad Sci U S A 93:4851-4856, 1996
16. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039, 1995
17. Ku DD, Zaleski JK, Liu S, Brock TA: Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265:H586-H592, 1993
18. Aiello LP Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori G, Ciulla TA, Ways K, Jirousek M, Smith LE, King GL: Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46:1473-1480, 1997
19. Wu HM, Huang Q, Yuan Y, Granger HJ: VEGP induces NO-dependent hyperpermeability in coronary venules. Am J Physiol 271:H2735-H2739, 1996
20. Tilton RG, Kawamura T, Chang KG, Ido Y, Bjercke RJ, Stephan CC, Brock TA, Williamson JR: Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest 99:2192-2202, 1997
21. Sirois MG, Edelman ER: VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am J Physiol 272.-H2746-H2756, 1997
22. Natarajan R, Bai W, Lanting L, Gonzales N, Nadler J: Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol 273:H2224-H2231, 1997
23. Williams B, Gallacher B, Patel H, Orme C: Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46:1497-1503, 1997
24. Sone S, Kawakami Y, Okuda Y, Kondo S, Hanatani M, Suzuki H, Yamashita K: Vascular endotheJial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 221:193-193, 1996
25. Shweiki D, Neeman M, Itin A, Keshet E: Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A 92:768-772, 1995
26. Hirata C, Nakano K, Nakamura N, Kitagawa Y, Shigeta H, Hasegawa G, Ogata M, Ikeda T, Sawa H, Nakamura K, Ienaga K, Obayashi H, Kondo M: Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Müller cells. Biochem Biophys Res Commun 236:712-715, 1997
27. Lowe WL, Florkiewicz RZ, Yorek MA, Spanheimer RG, Albrecht BN: Regulation of growth factor mRNA levels in the eyes of diabetic rats. Metabolism 44:1038-1045, 1995
28. McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE: Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci U S A 89:8150-8154, 1992
29. Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L: Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 108:869-872, 1990
30. Boulton M, Gregor Z, McLeod D, Charteris D, Jarvis-Evans J, Moriarty P, Khaliq A, Foreman D, Allamby D, Bardsley B: Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol 81:228-233, 1997
31. Hill DJ, Flyvbjerg A, Arany E, Lauszus FF, Klebe JG: Increased levels of serum fibroblast growth factor-2 in diabetic pregnant women with retinopathy. J Clin Endocrinol Metab 82:1452-1457, 1997
32. Hamet P, Sugimoto H, Umeda F, Lecavalier L, Franks DJ, Orth DN, Chiasson JL: Abnormalities of platelet-derived growth factors in insulin-dependent diabetes. Metabolism 34:25-31, 1985
33. Lee YJ, Shin SJ, Lin SR, Tan MS, Tsai JH: Increased expression of heparin binding epidermal growth-factor-like growth factor mRNA in the kidney of streptozotocin-induced diabetic rats. Biochem Biophys Res Commun 207:216-222, 1995
34. Che W, Asahi M, Takahashi M, Kaneto H, Okado A, Higashiyama S, Taniguchi N: Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells: the involvement of reactive oxygen species formation and a possible implication of atherogenesis in diabetes. J Biol Chem 272:18453-18459, 1997
35. Inaba T, Ishibashi S, Gotoda T, Kawamura M, Morino N, Nojima Y, Kawakami M, Yazaki Y, Yamada N: Enhanced expression of platelet-derived growth factor-beta receptor by high glucose: involvement of platelet-derived growth factor in diabetic angiopathy. Diabetes 45:507-512, 1996
36. Sharp PS: Growth factors in the pathogenesis of diabetic retinopathy. Diabetes Rev 3:164-176, 1995
37. Koehler G, Milstein C: Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 6:511-519, 1976
38. Bjercke RJ, Cook G, Rychlik N, Gjika HB, Vunakis HV, Longone JJ: Stereospecific monoclonal antibodies to nicotine and cotinine and their use in enzyme-linked immunosorbent assays. J Immunol Methods 90:203-213, 1986
39. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 138:213-221, 1991
40. Lundberg C, Gerdin B: The inflammatory reaction in an experimental model of open wounds in the rat: the effect of arachidonic acid metabolites. Eur J Pharmacol 97:229-238, 1984
41. Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J: Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 87:31-38, 1990
42. Pugliese G, Tilton RG, Speedy A, Chang K, Province MA, Kilo C, Williamson JR: Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity. Metabolism 39:690-697, 1990
43. Tilton RG, Chang K, Nyengaard JR, Van den Enden M, Mo Y, Williamson JR: Inhibition of sorbitol dehydrogenase: effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 44:234-242, 1995
44. Middaugh CR, Mach H, Burke CJ, Volkin DB, Dabora JM, Tsai PK, Brunei- MW, Ryan JA, Marfia KE: Nature of the interaction of growth factors with suramin. Biochemistry 31:9016-9024, 1992
45. Hosang M: Suramin binds to platelet-derived growth factor and inhibits its biological activity. J Cell Biochem 29:265-273, 1985
46. Takano S, Gately S, Neville ME, Herblin WF, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S: Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res 54:2654-2660, 1994
47. Waltenberger J, Mayr U, Frank H, Hombach V: Suramin is a potent inhibitor of vascular endothelial growth factor: a contribution to the molecular basis of its antiangiogenic action. J Mol Cell Cardiol 28:1523-1529, 1996
48. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G: Hypotensive activity of fibroblast growth factor. Science 254:1208-1210, 1991
49. Rosenblatt S, Irikura K, Caday CG, Finklestein SP, Moskowitz MA: Basic fibroblast growth factor dilates rat pial arterioles. J Cereb Blood Flow Metab 14:70-74, 1994
50. Kadota O, Ohta S, Kumon Y, Sakaki S, Matsuda S, Sakanaka M: Role of basic fibroblast growth factor in the regulation of rat basilar artery tone in vivo. Neurosci Lett 199:99-102, 1995
51. Hackshaw KV, Shi Y: Fibroblast growth factors mobilize peritoneal macrophage intracellular calcium. Life Sci 54:661-670, 1994
52. Zhu DL, Herembert T, Caruelle D, Caruelle JP, Marche P: Involvement of calcium channels in fibroblast growth factor-induced activation of arterial cells in spontaneously hypertensive rats. J Cardiovasc Pharmacol 23:395-400, 1994
53. Wu HM, Yuan Y, McCarthy M, Granger HJ: Acidic and basic FGFs dilate arte holes of skeletal muscle through a NO-dependent mechanism. Am J Physiol 271:H1087-H1093, 1996
54. Kostyk SK, Kourembanas S, Wheeler EL, Medeiros D, McQuillan LP, D'Amore PA, Braunhut SJ: Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells. Am J Physiol 269:H1583-H1589, 1995
55. 2 activity. J Biol Chem 269:3219-3225, 1994
56. Ahmed A, Plevin R, Shoaibi MA, Fountain SA, Ferriani RA. Smith SK: Basic FGF activates phospholipase D in endothelial cells in the absence of inositollipid hydrolysis. Am J Physiol 266:C206-C212, 1994
57. Frank RN, Amin R, Kennedy A, Hohman TC: An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch Ophthalmol 115:1036-1047, 1997
58. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272:728-731, 1996
59. Taniguchi N, Kaneto H, Asahi M, Takahashi M, Wenyi C, Higashiyama S, Fujii J, Suzuki K, Kayanoki Y: Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes 45:S81-S83, 1996
60. Yamagishi S, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, Yamamoto H: Advanced glycation end products-driven angiogenesis in vitro: induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272:8723-8730, 1997
61. Ido Y, Chang K, Smith S, Tilton RG, Williamson JR: Vascular dysfunction in granulation tissue induced by glycated albumin is prevented by antibodies against vascular endothelial growth factor and by a selective inhibitor of the β isoform of protein kinase C (Abstract). Diabetes 47 (Suppl. 1):A24, 1998
62. Pasumarthi KBS, Jin Y, Cattini PA: Cloning of the rat fibroblast growth factor-2 promoter region and its response to nutogenic stimuli in glioma C6 cells. J Neurockem 68:898-908, 1997
63. Abraham JA, Whang JL, Tumolo A, Mergia A, Friedman J, Gospodarowicz D, Fiddes JC: Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J 5:2523-2528, 1986
64. Shima DT, Kuroki M, Deutsch U, Ng Y, Adamis AP, D'Amore PA: The mouse gene for vascular endothelial growth factor: genomic structure, definition of the transcriptional unit, and characterization of transcriptional and posttranscriptional regulatory sequences. J Biol Chem 271:3877-3883, 1996
65. Shih HM, Liu Z, Towle HC: Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription. J Biol Chem 270:21991-21997, 1995
66. Girard J, Ferre P, Foufelle F: Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Annu Rev Nutr 17:325-352, 1997